News
Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
Morning. Today, we see march-in rights return to the headlines, ponder how Eli Lilly’s plan to hike list prices in Europe may ...
When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, and cybersecurity are at risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results